Evidence map›Paper›PMID 22281142›Full record

ReviewThe Lancet. Infectious diseases2012

Surgical treatment of drug-resistant tuberculosis.

Russell R Kempker, Sergo Vashakidze, Nelly Solomonia, Nino Dzidzikashvili, Henry M Blumberg

Abstract readCase ReportsReview
In one paragraph

Review in The Lancet. Infectious diseases, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 96 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Pulmonary tuberculosis and the surgeon.Lung India : official organ of Indian Chest Society · 2026
    Article
  5. Article
  6. Long term management of people with post-tuberculosis lung disease.The Korean journal of internal medicine · 2024
    Review
  7. Article
  8. Review
  9. Review
  10. Adjunctive surgery versus medical treatment among patients with cavitary multidrug-resistant tuberculosis.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2021
    Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Review
  16. Article
  17. Pulmonary function and respiratory health after successful treatment of drug-resistant tuberculosis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2019
    Article
  18. Treatment as prevention and other interventions to reduce transmission of multidrug-resistant tuberculosis.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2019
    Article
  19. Article
  20. Current Indications and Outcome of Pulmonary Resections for Tuberculosis Complications in Ibadan, Nigeria.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Russell R KempkerDivision of Infectious Diseases, Department of Medicine, Rollins School of Public Health, Emory University, Atlanta, GA 30303, USA. rkempke@emory.edu
Sergo Vashakidze
Nelly Solomonia
Nino Dzidzikashvili
Henry M Blumberg
National Center for Tuberculosis and Lung Disease · GEEmory University · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025008 · NCRR · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2007 to 2011
$29.0M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
Emory-Georgia TB Research Training ProgramD43TW007124 · FIC · EMORY UNIVERSITY · PI HENRY M BLUMBERG, Nestani Tukvadze · 2004 to 2026
$4.6M
FIC NIH HHS D43 TW007124FIC NIH HHS D43TW007124FIC NIH HHS D43TW007124-06S1NCATS NIH HHS UL1 TR000454NCRR NIH HHS UL1 RR025008NCRR NIH HHS UL1RR025008
6 · The paper itself

Abstract

The global emergence and spread of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis has led to the re-examination of surgery as a possible adjunctive treatment. We present the case of a 26-year-old HIV-seronegative patient with XDR pulmonary tuberculosis refractory to medical therapy. Surgical resection of the patient's solitary cavitary lesion was done as adjunctive treatment, and a successful outcome with a combination of surgery and drug therapy was achieved. We review the history of surgical therapy for tuberculosis and reports of its role in treatment of MDR and XDR tuberculosis. 26 case series and cohort studies were included, and together showed that surgical resection is beneficial in the treatment of drug-resistant tuberculosis. However, the results might not be applicable in all settings because investigations were observational and typically included patients with less severe disease, and all surgeries were done at specialised thoracic-surgery centres. Well designed studies are needed to establish the efficacy of surgery in treatment of drug-resistant tuberculosis.

Indexed as

Mycobacterium tuberculosisAdultAntitubercular AgentsExtensively Drug-Resistant TuberculosisHumansMaleTuberculosis, PulmonaryAntitubercular Agents

Identifiers

PMID22281142
PMCPMC3741680
OpenAlexW1976477601

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.